2Üsküdar University, Neuropsychopharmacology Research and Application Center, Üsküdar, İstanbul, 34662, Türkiye
3Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Üsküdar University, Üsküdar, İstanbul, 34662, Türkiye
Abstract
This study evaluates the protective effect of Hesperidin (HES), flavanoglycone, during pre-ec-lampsia developed pregnancy. The pregnant rats were randomly divided into five groups as Control, L-NAME (25 mg/kg), HES (100 mg/kg), L-NAME-HES and L-NAME P-HES. After the 13th day of pregnancy, the chemicals were administrated until the 20th day. 20 days after the offspring’s birth, they were separated from their mothers and all rats were sacrificed after 6 weeks’ time. Serum samples were analyzed for levels of Glutathione (GSH), lipid peroxidation (LPO), and neuron-specific enolase (NSE) activity. Urine samples were analyzed for the pro-teinuria. While Proteinuria and LPO level increasing, GSH levels decreased in the L-NAME group when compared to the Control. As we compared L-NAME group with the L-NAME-HES and L-NAME P-HES groups, the GSH levels increased significantly while LPO levels in the HES, L-NAME-HES, L-NAME P-HES groups were decreasing. The NSE activity signifi-cantly increased in the L-NAME group compared to the Control. In contrast to the L-NAME group, its activity decreased in HES, L-NAME-HES and L-NAME P-HES groups significantly. Briefly, it can be said that HES has a significant effect on both the LPO levels and the NSE activity in the case of pre-eclampsia.